<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03898752</url>
  </required_header>
  <id_info>
    <org_study_id>MiOxysis_Skive</org_study_id>
    <nct_id>NCT03898752</nct_id>
  </id_info>
  <brief_title>Is Oxidative Stress in Semen Reduced by Lifestyle Intervention</brief_title>
  <official_title>Is Oxidative Stress in Semen Reduced by Lifestyle Intervention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peter Humaidan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Regionshospitalet Viborg, Skive</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study we aim to investigate whether a 3-month life-style intervention would reduce
      oxidative stress (OS) in semen in men of infertile couples attending IVF-treatment. Men with
      a DFI above 15% (SCSA method) are recruited for intervention with a 3-month follow-up.

      It is hypothesized that men who also have a OS above 1.34 using a novel OS diagnostic method
      (MiOXSYS) respond better to antioxidant treatment with a change in OS and DFI. The primary
      outcome is the change in OS following the intervention. Secondary outcomes are morphological
      semen parameters and DNA fragmentation index.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2018</start_date>
  <completion_date type="Anticipated">June 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>All men with DFI &gt;15 (SCSA method) are assigned to life-style intervention.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Oxidative stress</measure>
    <time_frame>3 months</time_frame>
    <description>Oxidative stress as measured with MiOxysis (Ayto Bioscience inc).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Semen quality</measure>
    <time_frame>3 months</time_frame>
    <description>Morphological semen parameters using WHO recommendation for semen analysis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>DNA fragmentation index</measure>
    <time_frame>3 months</time_frame>
    <description>DNA fragmentation index as measured by the method by SPZlab A/S (SCSA method)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Oligospermia</condition>
  <arm_group>
    <arm_group_label>Lifestyle intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Diet, omega-3 fish oil (1g daily), CoQ10 (100 mg/day) and a normal Multi-vitamin, Smoking cessation, weight loss, exercise,</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Omega 3</intervention_name>
    <description>Omega 3: 1g daily for 3 months CoQ10: 100 mg daily for 3 months Multivitamin: 1 normal multivitamin tablet daily for 3 months</description>
    <arm_group_label>Lifestyle intervention</arm_group_label>
    <other_name>Coenzyme Q10 (CoQ10)</other_name>
    <other_name>Multi-vitamin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  MiOxysis above 1.34

          -  Attending IVF treatment for unknown or male factor infertility.

        Exclusion Criteria:

          -  Genetic diseases

          -  Azospermia
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Peter Humaidan, MD</last_name>
    <phone>78 44 57 60</phone>
    <phone_ext>+45</phone_ext>
    <email>peter.humaidan@midt.rm.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Fertility Clinic Skive</name>
      <address>
        <city>Skive</city>
        <state>Central Denmark Region</state>
        <zip>7800</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Humaidan, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>April 1, 2019</study_first_submitted>
  <study_first_submitted_qc>April 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 2, 2019</study_first_posted>
  <last_update_submitted>February 17, 2020</last_update_submitted>
  <last_update_submitted_qc>February 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Regionshospitalet Viborg, Skive</investigator_affiliation>
    <investigator_full_name>Peter Humaidan</investigator_full_name>
    <investigator_title>Professor, MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Oligospermia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coenzyme Q10</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Not allowed by Danish legislation to publish individual meta-data.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

